Published in Vaccine on October 01, 1995
Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: potential for vaccine applications. Bioconjug Chem (2012) 0.92
Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens. Infect Immun (2000) 0.91
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems. Vaccines (Basel) (2016) 0.75
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol (2004) 2.14
Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol (1999) 2.13
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol (1989) 2.03
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg (1997) 1.87
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61
Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol (1987) 1.61
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) (1988) 1.59
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer (1995) 1.48
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J (1997) 1.40
Acute hepatitis and roxithromycin. Lancet (1993) 1.39
[Rectoscopy and Hemoccult II in irritable colon. A prospective study]. Ugeskr Laeger (1990) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Melanocytes in the anal canal epithelium. Histopathology (1991) 1.32
Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comp Med (2000) 1.30
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
The Funen Adenoma Follow-up Study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol (1993) 1.19
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma Follow-up Study. Scand J Gastroenterol (1995) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency. Scand J Gastroenterol (1992) 1.10
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
The Funen Adenoma Follow-Up Study. Characteristics of patients and initial adenomas in relation to severe dysplasia. Scand J Gastroenterol (1993) 1.09
Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. Cancer (1995) 1.08
Assessments of clonal composition of colorectal adenomas by FISH analysis of chromosomes 1, 7, 13 and 20. Int J Cancer (2001) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Clonal karyotypic abnormalities in colorectal adenomas: clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer (1994) 1.05
The anal transitional zone. Location and extent. Acta Pathol Microbiol Scand A (1979) 1.04
Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Scand J Gastroenterol (2003) 1.03
Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer Genet Cytogenet (1998) 1.00
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Follow-up after radical surgery for colorectal cancer. Design of a randomized study. Scand J Gastroenterol Suppl (1988) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. Acta Pathol Microbiol Immunol Scand A (1986) 0.98
The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis (2001) 0.98
The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis (1997) 0.97
Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience (2006) 0.97
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol (1995) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Gastric ulcer. II. Surgical treatment. Acta Chir Scand (1973) 0.93
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand A (1981) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Arthritis and collagenous colitis. Report of a case with concomitant chronic polyarthritis and collagenous colitis. Scand J Rheumatol (1983) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Bleeding gastric ulcer. Surgical and non-surgical treatment of 225 patients. Scand J Gastroenterol (1972) 0.92
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester. Clin Exp Immunol (2002) 0.90
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
Histochemical characteristics of mucins in the small intestine. A comparative study of normal mucosa, benign epithelial tumours and carcinoma. Histochem J (1979) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
Mucin histochemistry of the anal canal epithelium. Studies of normal anal mucosa and mucosa adjacent to carcinoma. Histochem J (1981) 0.88
Tumor detection with 131I-labeled human monoclonal antibody COU-1 in patients with suspected colorectal carcinoma. Cancer Res (1993) 0.88
The expression of p53, Ki-67 and urokinase plasminogen activator receptor in colorectal adenomas with true invasion and pseudoinvasion. APMIS (1999) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87